| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Rezolute Inc (NASDAQ: RZLT)
RZLT Technical Analysis
5
| As on 11th Dec 2025 RZLT STOCK Price closed @ 1.40 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.36 & Strong Sell for SHORT-TERM with Stoploss of 4.89 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RZLTSTOCK Price
| Open | 1.23 | Change | Price | % |
| High | 1.61 | 1 Day | -9.54 | -87.20 |
| Low | 1.07 | 1 Week | -7.49 | -84.25 |
| Close | 1.40 | 1 Month | -8.13 | -85.31 |
| Volume | 127846720 | 1 Year | -3.64 | -72.22 |
| 52 Week High 10.94 | 52 Week Low 1.40 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| NVDA | 180.93 | -1.55% |
| PETS | 2.98 | 68.36% |
| RZLT | 1.40 | -87.20% |
| LMDX | 0.02 | 0.00% |
| YGMZ | 0.02 | -66.67% |
| AKTS | 0.04 | 0.00% |
| PLUG | 2.36 | 4.42% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| RZLT Daily Charts |
RZLT Intraday Charts |
Whats New @ Bazaartrend |
RZLT Free Analysis |
|
|
RZLT Important Levels Intraday
| RESISTANCE | 2.44 |
| RESISTANCE | 2.11 |
| RESISTANCE | 1.90 |
| RESISTANCE | 1.69 |
| SUPPORT | 1.11 |
| SUPPORT | 0.90 |
| SUPPORT | 0.69 |
| SUPPORT | 0.36 |
RZLT Forecast December 2025
| 4th UP Forecast | 4.19 |
| 3rd UP Forecast | 3.3 |
| 2nd UP Forecast | 2.74 |
| 1st UP Forecast | 2.19 |
| 1st DOWN Forecast | 0.61 |
| 2nd DOWN Forecast | 0.06 |
| 3rd DOWN Forecast | -0.5 |
| 4th DOWN Forecast | -1.39 |
RZLT Weekly Forecast
| 4th UP Forecast | 3.42 |
| 3rd UP Forecast | 2.77 |
| 2nd UP Forecast | 2.37 |
| 1st UP Forecast | 1.97 |
| 1st DOWN Forecast | 0.83 |
| 2nd DOWN Forecast | 0.43 |
| 3rd DOWN Forecast | 0.03 |
| 4th DOWN Forecast | -0.62 |
RZLT Forecast2025
| 4th UP Forecast | 21.42 |
| 3rd UP Forecast | 15 |
| 2nd UP Forecast | 11.03 |
| 1st UP Forecast | 7.06 |
| 1st DOWN Forecast | -4.26 |
| 2nd DOWN Forecast | -8.23 |
| 3rd DOWN Forecast | -12.2 |
| 4th DOWN Forecast | -18.62 |
Rezolute Inc ( NASDAQ USA Symbol : RZLT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RZLT Business Profile
Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It is also developing RZ402, a selective and potent plasma kallikrein inhibitor, which is in Phase 1 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California. Address: 201 Redwood Shores Parkway, Redwood City, CA, United States, 94065
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service